Long-term oral nitrate therapy is associated with adverse outcome in diabetic patients following elective percutaneous coronary intervention

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Hang Yiu, Kai ^a   Pong, Vincent ^a   Wah Siu, Chung ^a   Pak Lau, Chu ^a   Fat Tse, Hung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diabetes; MACEs; Nitrate

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOSORBIDE 5 NITRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATIN; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; INCIDENCE; INSULIN TREATMENT; LONG TERM CARE; MAJOR ADVERSE CARDIOVASCULAR EVENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; REVASCULARIZATION; SMOKING; STROKE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FEMALE; HONG KONG; HUMANS; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 79959873229     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-52     Document Type: Article

References (23)

1. Fraker TD, Fihn SD, . Writing on behalf of the Chronic Stable Angina Writing Committee Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association task force on practice guidelines writing group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. Circulation 2007, 116:2762-2772. 10.1161/CIRCULATIONAHA.107.187930, 17998462, Writing on behalf of the Chronic Stable Angina Writing Committee.
2. Feldman DN, Gade CL, Slotwiner AJ, Parikh M, Bergman G, Wong SC, Minutello RM, . New York State Angioplasty Registry Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (< 60, 60 to 80, and > 80 Years) (from the New York State Angioplasty Registry). Am J Cardiol 2006, 98:1334-1339. 10.1016/j.amjcard.2006.06.026, 17134624, New York State Angioplasty Registry.
3. Berry C, Tardif J-C, Bourassa MG. Coronary heart disease in patients with diabetes: Part II: Recent advances in coronary revascularization. J Am Coll Cardiol 2007, 49:643-656. 10.1016/j.jacc.2006.09.045, 17291929.
4. Csont T, Ferdinandy P. Cardioprotective effects of glyceryl trinitrate: beyond vascular nitrate tolerance. Pharmacol Ther 2005, 105:57-68. 10.1016/j.pharmthera.2004.10.001, 15626455.
5. Ishikawa K, Kanamasa K, Ogawa I, Takenaka T, Naito T, Kamata N, Yamamoto T, Nakai S, Hama J, Oyaizu M, Kimura A, Yamamoto K, Aso N, Arai M, Yabushita H, Katori Y. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. Jpn Circ J 1996, 60:788.
6. Kanamasa K, Hayashi T, Kimura A, Ikeda A, Ishikawa K. Long-term, continuous treatment with both oral and transdermal nitrates increases cardiac events in healed myocardial infarction patients. Angiology 2002, 53:399-408. 10.1177/000331970205300405, 12143944.
7. Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C. Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group. Am Heart J 1999, 138:577-585. 10.1016/S0002-8703(99)70163-8, 10467211.
8. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, . Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
9. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979, 59:607-609.
10. ISIS-4 Collaborative gtoup ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995, 345:669-685. ISIS-4 Collaborative gtoup.
11. Gruppo italiano per lo Studio della Spravvivenza nell'Infarto Miocardico: GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994, 343:1115-1122.
12. Takara A, Ogawa H, Endoh Y, Mori F, Yamaguchi J, Takagi A, Koyanagi R, Shiga T, Kasanuki H, Hagiwara N. Long-term prognosis of diabetic patients with acute myocardial infarction in the era of acute revascularization. Cardiovasc Diabetol 2010, 9:1-7. 10.1186/1475-2840-9-1, 2815698, 20047694.
13. Kones R. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization. Vasc Health Risk Manag 2010, 6:749-74. 2941787, 20859545.
14. Gori T, Mak SS, Kelly S, Parker JD. Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans. J Am Coll Cardiol 2001, 38:1096-1101. 10.1016/S0735-1097(01)01510-8, 11583888.
15. Kaesemeyer WH, Ogonowski AA, Jin L, Caldwell RB, Caldwell RW. Endothelial nitric oxide synthase is a site of superoxide synthesis in endothelial cells treated with glyceryl trinitrate. Br J Pharmacol 2000, 131:1019-1023. 10.1038/sj.bjp.0703665, 1572421, 11053225.
16. Zierhut W, Ball HA. Prevention of vascular nitroglycerin tolerance by inhibition of protein kinase C. Br J Pharmacol 1996, 119:3-5. 1915730, 8872349.
17. Brownlee M. The Pathobiology of Diabetic Complications: A Unifying Mechanism. Diabetes 2005, 54:1615-1625. 10.2337/diabetes.54.6.1615, 15919781.
18. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 2000, 97:12222-12226. 10.1073/pnas.97.22.12222, 17322, 11050244.
19. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 2000, 49:1939-1945. 10.2337/diabetes.49.11.1939, 11078463.
20. Chirkov YY, Chirkova LP, Horowitz JD. Nitroglycerin Tolerance at the Platelet Level in Patients With Angina Pectoris. Am J Cardiol 1997, 80:128-131. 10.1016/S0002-9149(97)00305-6, 9230146.
21. Iwase E, Tawata M, Aida K, Ozaki Y, Kume S, Satoh K, Qi R, Onaya T. A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus. Metabolism 1998, 47:699-705. 10.1016/S0026-0495(98)90034-8, 9627370.
22. Price MJ, Nayak KR, Barker CM, Kandzari DE, Teirstein PS. Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention. Am J Cardiol 2009, 103:1339-43. 10.1016/j.amjcard.2009.01.341, 19427425.
23. Choi EK, Koo BK, Kim HS, Cho YM, Kang HJ, Cho YS, Chung WY, Chae IH, Choi DJ, Oh BH, Park YB, Choi YS. Prognostic significance of asymptomatic coronary artery disease in patients with diabetes and need for early revascularization therapy. Diabet Med 2007, 24:1003-11. 10.1111/j.1464-5491.2007.02182.x, 17509072.